Atlas Trials

SMS 2: Impact of Cancer Therapy on the Somatic Mutational Landscape of Normal Tissues

Clinical trial NCT06832150 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT06832150
Sponsor
The Wellcome Sanger Institute
Status
ENROLLING_BY_INVITATION
Study type
OBSERVATIONAL
Somatic MutationCancer
Start date
2024-11-26
Primary completion
2028-05-14
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.